Abstract
Background
The Helicobacter pylori eradication rate with standard triple therapy is very low. H. pylori is known to require the nickel-containing metalloenzymes urease and NiFe-hydrogenase to survive at the low pH environment in the stomach.
Aim
To compare the H. pylori eradication rate of a nickel free-diet associated with standard triple therapy and standard triple therapy alone as the first-line regimen.
Methods
Fifty-two sex- and age-matched patients at the first diagnosis of H. pylori infection were randomized 1:1 into two different therapeutic schemes: (1) standard LCA (26 patients): lansoprazole 15 mg bid, clarithromycin 500 mg bid and amoxicillin 1,000 mg bid for 7 days with a common diet; (2) standard LCA plus a nickel free-diet (NFD-LCA) (26 patients). Patients followed 30 days of a nickel-free diet plus a week of lansoprazole 15 mg bid, clarithromycin 500 mg bid and amoxicillin 1,000 mg bid starting from day 15 of the diet.
Results
All patients completed the study. A significantly higher eradication rate was observed in the NFD-LCA group (22/26) versus LCA group (12/26) (p < 0.01). Only a few patients (9 of 52) reported the occurrence of mild therapy-related side effects, without any significant differences between the two groups.
Conclusions
The addition of a nickel-free diet to standard triple therapy significantly increases the H. pylori eradication rate. The reduction of H. pylori urease activity due to the nickel-free diet could expose the bacterium to gastric acid and increase H. pylori's susceptibility to amoxicillin. Further studies are necessary to confirm this preliminary result.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bijlsma JJ, Lie-A-Ling M, Nootenboom IC, et al. Identification of loci essential for the growth of Helicobacter pylori under acidic conditions. J Infect Dis. 2000;182:1566–1569.
Stingl K, Altendorf K, Bakker EP. Acid survival of Helicobacter pylori: how does urease activity trigger cytoplasmic pH homeostasis? Trends Microbiol. 2002;10:70–74.
Sachs G, Scott DR, Wen Y. Gastric infection by Helicobacter pylori. Curr Gastroenterol Rep. 2011;13:540–546.
Maier RJ, Fu C, Gilbert J, et al. Hydrogen uptake hydrogenase in Helicobacter pylori. FEMS Microbiol Lett. 1996;141:71–76.
Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772–781.
Glupczynski Y, Mégraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001;20:820–823.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34–42.
Bury-Moné S, Thiberge JM, Contreras M, et al. Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori. Mol Microbiol. 2004;53:623–638.
Burne RA, Chen YY. Bacterial ureases in infectious diseases. Microbes Infect. 2000;2:533–542.
Denkhaus E, Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Oncol Hematol. 2002;42:35–56.
de Boer WA, Thys JC, Borody TJ, et al. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol. 1996;8:641–643.
Calnan CD, Fregert S, Magnusson B. The international contact dermatitis research group. Cutis. 1976;18:708–710.
Czarnobilska E, Jenner B, Kaszuba-Zwoinska J et al. Contact allergy to nickel: patch test score correlates with IL-5, but not with IFN-gamma nickel-specific secretion by peripheral blood lymphocytes. Ann Agric Environ Med. 2009;16:37–41, 51.
Buckley MJ, Scanlon C, McGurgan P, O’Morain CA. A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol.. 1997;29:495–500.
Minelli M, Schiavino D, Musca F, et al. Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome. Int J Immunopathol Pharmacol. 2010;23:193–201.
Schiavino D, Nucera E, Alonzi C, et al. A clinical trial of oral hyposensitization in systemic allergy to nickel. Int J Immunopathol Pharmacol. 2006;19:593–600.
Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht IV/florence consensus report. Gut. 2012;61:646–664.
Gatta L, Di Mario F, Vaira D, et al. Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med. 2011;6:35–39.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campanale, M., Nucera, E., Ojetti, V. et al. Nickel Free-Diet Enhances the Helicobacter pylori Eradication Rate: A Pilot Study. Dig Dis Sci 59, 1851–1855 (2014). https://doi.org/10.1007/s10620-014-3060-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-014-3060-3